Infinity Pharmaceuticals Inc(INFI)因证券欺诈案已经于近日被投资者集体诉讼至法院。在目前的诉讼中投资者指控该公司及部分高管在本案诉讼期间进行虚假陈述,违反证券法令投资者受损。投资者向法院申请判令被告赔偿因...查看全文
美股滚雪球2023-02-24 09:51
$美制药(MEIP)$ 和$无限制药(INFI)$ 宣布了一项合并协议,将以全股票交易方式合并。
根据条款,在交易完成时,Infinity (INFI)将成为MEI Pharma (MEIP)的全资子公司,预计于2023年中期完成。
合并后的公司将有三个开发项目,其中eganelisib是一种口服免疫肿瘤候选药物,针对头颈部鳞状细胞...查看全文
$无限制药(INFI)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001113148-22-000019 Act: 34 Size: 297 KB 网页链接
$无限制药(INFI)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001113148-22-000018 Act: 34 Size: 4 MB 网页链接
$无限制药(INFI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-22-028234 Size: 8 KB 网页链接
$无限制药(INFI)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000834237-22-010180 Act: 34 Size: 12 KB 网页链接
$无限制药(INFI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-22-023338 Size: 14 KB 网页链接
$无限制药(INFI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-22-023321 Size: 15 KB 网页链接
$无限制药(INFI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-22-023318 Size: 12 KB 网页链接
$无限制药(INFI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-22-023319 Size: 15 KB 网页链接
$无限制药(INFI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-22-023313 Size: 15 KB 网页链接
$无限制药(INFI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-22-023308 Size: 14 KB 网页链接